Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Reliable Biopharmaceutical Expands Production Capacity at St. Louis, Missouri, Plant

02/16/2016
Reliable Biopharmaceutical expanded its manufacturing capacity for Lithium Dodecyl Sulfate (Lithium Lauryl Sulfate) and Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate), at its production facility in St. Louis, Missouri.

Lithium Dodecyl Sulfate and Sodium Dodecyl Sulfate are used in the manufacture of diagnostic tests and in the pharmaceutical industry for protein isolation and purification. Also known as Dodecyl Lithium Sulfate or Lithium Lauryl Sulfate, LDS and SDS are sold both in research and bulk containers.

Reliable Biopharmaceutical is an integrated developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceuticals and biologics.

“Reliable continues to leverage our quality systems and proprietary purification technology to produce the highest quality excipients in the world,” said David Feldker President/CEO. “We are committed to our customer’s success and their requirement for high purity ingredients.”

According to the firm, RB has established a strong position as a leading developer and manufacturer of complex generic injectable APIs. The company has a number of DMFs that have been accepted by Regulatory Agencies and has more in various stages of development. RB's products are the active ingredients for leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious and life threatening illnesses. RB also manufactures critical processing aids for the pharmaceutical industry and currently supplies these products to many of the world's leading pharmaceutical and biotechnology companies.

Share

Exclusive Research